MediPoint: Total Ankle Replacement - APAC Analysis and Market Forecasts
NEW YORK, April 16, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
MediPoint: Total Ankle Replacement - APAC Analysis and Market Forecasts
MediPoint: Total Ankle Replacement - APAC Analysis and Market Forecasts
Summary
Ankle arthritis is a severe and debilitating problem with notable increasing prevalence in both the developed and developing world. In a society constantly seeking out a modern lifestyle, sports-related injuries, trauma, aging, and obesity are contributing to an increased incidence of ankle arthritis. Total ankle replacement (TAR) enables implantation of prosthesis within the diseased native ankle joint to help patients maintain their ankles' range of motion. Promising results of newer generation prostheses revived interest in TAR and fueled further innovations in the prosthetic design. After decades of trial and error, TAR is now becoming a promising option for late-stage ankle arthritis patients as an alternative to ankle fusion, which has historically been presumed to be the gold-standard procedure. This report focuses on the TAR markets in APAC. This report identifies unmet needs in the market, surgeon attitudes towards current TAR prostheses, and the future of TAR in the face of rapid technological advancement.
Scope
- An overview of Ankle arthritis, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized APAC TAR market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018.
- Investigation of current and future market competition for TAR
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the TAR device sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as oncologists
Reasons to buy
- Understand the trends shaping and driving APAC TAR Market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in APAC TAR Market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What's the next big thing in APAC TAR market landscape? Identify, understand and capitalize.
Table of Contents
1 Table of Contents 5
1.1 List of Tables 10
1.2 List of Figures 12
2 Introduction 14
2.1 Catalyst 14
3 Disease Overview 15
3.1 Anatomy and Physiology 15
3.2 Pathophysiology 16
3.2.1 Overview 16
3.2.2 Post-Traumatic Arthritis 17
3.2.3 Inflammatory Arthritis 18
3.2.4 Primary Osteoarthritis 19
3.2.5 Others 19
3.3 Clinical Presentation 20
3.3.1 Symptoms 20
3.3.2 Diagnosis 21
3.4 Clinical Outcomes 22
3.4.1 Overview 22
3.4.2 Conservative Treatments 23
3.4.3 Joint-Preserving Surgeries 24
3.4.4 Definitive Procedures 26
3.5 Epidemiology 30
3.5.1 Prevalence 30
3.5.2 Treatments 31
3.6 Economic Impact 32
4 Competitive Assessment 34
4.1 Overview 34
4.2 Competitive Assessment 35
4.3 Two-Component Fixed-Bearing 36
4.3.1 Agility LP 36
4.3.2 Salto Talaris 39
4.3.3 INBONE II 41
4.3.4 TNK 44
4.3.5 Zimmer Trabecular Metal Total Ankle 46
4.4 Three-Component Mobile-Bearing 48
4.4.1 Scandinavian Total Ankle Replacement (STAR) 48
4.4.2 Mobility 51
4.4.3 Salto 53
4.4.4 HINTEGRA 55
4.4.5 BOX (Bologna-Oxford) 57
4.4.6 Zenith 59
4.4.7 CCI Evolution 61
5 Unmet Needs 63
5.1 Long-Term Follow-Up 64
5.2 Commitment to Medical Education 65
5.3 Advanced Biological Fixation 66
5.4 Minimal Bone Resection 68
5.4.1 Tibial Component 68
5.4.2 Talar Component 68
5.5 Mobile-Bearing versus Fixed-Bearing 69
5.6 Bespoke Instrumentation 71
5.7 Custom Prostheses 71
5.8 Revision Components 72
6 Pipeline Products 73
6.1 Overview 73
6.2 INBONE II Total Ankle with Calcaneal Stem Fixation 73
6.2.1 Overview 73
6.2.2 SWOT Analysis 74
6.3 Akilos Total Ankle System 75
6.3.1 Overview 75
6.3.2 SWOT Analysis 76
7 Industry Overview 77
7.1 Procedure Trends 77
7.2 Market Access 78
7.3 Reimbursement Trends 79
7.3.1 Japan 79
7.3.2 China and India 79
7.4 Regulatory Issues/Recalls 80
7.4.1 No Custom Devices for DePuy's Agility Total Ankle Prosthesis in the US 80
7.4.2 Medical Device Alert for Biomet's Ankle Evolutive System (AES) used in the UK 80
7.5 Mergers & Acquisitions/Key Partnerships 81
8 Current and Future Players 82
8.1 Overview 82
8.2 Trends in Corporate Strategy 82
8.3 Company Profiles 83
8.3.1 Small Bone Innovation, Inc. 83
8.3.2 DePuy Synthes 85
8.3.3 Tornier N.V. 87
8.3.4 Wright Medical Group, Inc. 88
8.3.5 Integra LifeSciences 91
8.3.6 Zimmer Holdings, Inc. 93
8.3.7 Corin Group 95
8.3.8 KYOCERA Medical Corporation 97
8.3.9 MatOrtho 99
8.3.10 Implants International 101
8.3.11 Other Companies 102
9 Market Drivers, Opportunities, and Barriers 103
9.1 Market Drivers 103
9.1.1 Superiority to Ankle Fusion 103
9.1.2 Rising Prevalence 105
9.1.3 Expanded Insurance Coverage 106
9.1.4 Availability of Long-Term Data 106
9.1.5 Increased Patient Awareness 107
9.1.6 Expected Launch of CE-Marked Devices 107
9.2 Opportunities 108
9.2.1 Expanded Indications 108
9.2.2 Advanced Biological Fixation Approaches 108
9.2.3 Revision TAR 109
9.2.4 Demand for Custom Prostheses 109
9.2.5 Demand for a Comprehensive Foot and Ankle Product Portfolio 110
9.2.6 Emerging Markets 110
9.3 Market Barriers 111
9.3.1 Preoperative Patient Selection 111
9.3.2 Long Learning Curve 112
9.3.3 Complications 113
9.3.4 Cost 113
9.3.5 Reimbursement 114
9.3.6 Substitutes 114
10 Country Outlooks and Forecasts 115
10.1 Major Markets Overview 115
10.2 Japan 117
10.2.1 Japan Market Analysis 117
10.3 China 119
10.3.1 China Market Analysis 119
10.4 India 121
10.4.1 India Market Analysis 121
11 Appendix 123
11.1 Abbreviations 123
11.2 Bibliography 124
11.3 Methodology 131
11.3.1 Coverage 131
11.3.2 Secondary Research 131
11.3.3 Primary Research 132
11.3.4 Forecasting Methodology 133
11.4 Physicians and Specialists Included in this Study 134
11.5 Physician Survey 135
11.6 About the Authors 135
11.6.1 Analysts 135
11.6.2 Global Head of Healthcare 136
11.7 About MediPoint 136
11.8 About GlobalData 137
11.9 Contact Us 137
11.10 Disclaimer 137
List of Tables
Table 1: Common Clinical Symptoms of Ankle Arthritis 20
Table 2: Indications and Contraindications of TAR 29
Table 3: Direct and Indirect Costs of Arthritis 32
Table 4: Currently Marketed Total Ankle Replacement Implants 34
Table 5: Product Profile – Agility LP 37
Table 6: SWOT Analysis – Agility LP 38
Table 7: Product Profile – Salto Talaris 40
Table 8: SWOT Analysis – Salto Talaris 40
Table 9: Product Profile – INBONE II 42
Table 10: SWOT Analysis – INBONE II 43
Table 11: Product Profile – TNK 45
Table 12: SWOT Analysis – TNK 45
Table 13: Product Profile – Zimmer Trabecular Metal Total Ankle 47
Table 14: SWOT Analysis - Zimmer Trabecular Metal Total Ankle 47
Table 15: Product Profile – STAR 49
Table 16: SWOT Analysis – STAR 50
Table 17: Product Profile – Mobility 52
Table 18: SWOT Analysis – Mobility 52
Table 19: Product Profile – Salto 54
Table 20: SWOT Analysis – Salto 54
Table 21: Product Profile – HINTEGRA 56
Table 22: SWOT Analysis – HINTEGRA 56
Table 23: Product Profile – BOX 58
Table 24: SWOT Analysis – BOX 58
Table 25: Product Profile – Zenith 60
Table 26: SWOT Analysis – Zenith 60
Table 27: Product Profile – CCI Evolution 62
Table 28: SWOT Analysis – CCI Evolution 62
Table 29: Overall Unmet Needs – Current Level of Attainment and Importance (n=30) 63
Table 30: Coating Methods of Currently Marketed TAR Implants 67
Table 31: Product Profile – INBONE II Total Ankle with Calcaneal Stem Fixation 73
Table 32: SWOT Analysis of INBONE II Total Ankle with Calcaneal Stem Fixation 74
Table 33: Product Profile – Akilos 76
Table 34: SWOT Analysis – Akilos 76
Table 35: Company Profile – Small Bone Innovations 83
Table 36: Portfolio Assessment – Small Bone Innovations, 2013 83
Table 37: SBi's Foot and Ankle Business SWOT Analysis, 2013 84
Table 38: Company Profile – DePuy Synthes Companies 85
Table 39: DePuy's Total Ankle Replacement Portfolio Assessment, 2013 86
Table 40: DePuy's Foot and Ankle Business SWOT Analysis, 2013 86
Table 41: Company Profile – Tornier N.V. 87
Table 42: Tornier's Total Ankle Replacement Portfolio Assessment, 2013 87
Table 43: Tornier's Foot and Ankle Business SWOT Analysis, 2013 88
Table 44: Company Profile – Wright Medical Group 89
Table 45: Wright Medical's Total Ankle Replacement Portfolio Assessment, 2013 90
Table 46: Wright Medical's Foot and Ankle Business SWOT Analysis, 2013 90
Table 47: Company Profile – Integra LifeSciences 91
Table 48: Integra's Total Ankle Replacement Portfolio Assessment, 2013 91
Table 49: Integra's Foot and Ankle Business SWOT Analysis, 2013 92
Table 50: Company Profile – Zimmer Holdings 93
Table 51: Zimmer Holding's Total Ankle Replacement Portfolio Assessment, 2013 93
Table 52: Zimmer's Foot and Ankle Business SWOT Analysis, 2013 94
Table 53: Company Profile – Corin Group 95
Table 54: Corin Group's Total Ankle Replacement Portfolio Assessment, 2013 95
Table 55: Corin Group's Foot and Ankle Business SWOT Analysis, 2013 96
Table 56: Company Profile – KYOCERA Medical Corporation 97
Table 57: KYOCERA Medical's Total Ankle Replacement Portfolio Assessment, 2013 97
Table 58: KYOCERA Medical's Orthopedic Devices Business SWOT Analysis, 2013 98
Table 59: Company Profile - MatOrtho 99
Table 60: MatOrtho's Total Ankle Replacement Portfolio Assessment, 2013 99
Table 61: MatOrtho's Orthopedic Devices Business SWOT Analysis, 2013 100
Table 62: Company Profiles – Implants International 101
Table 63: Implants International's Total Ankle Replacement Portfolio Assessment, 2013 101
Table 64: Implants International's Orthopedic Devices Business SWOT Analysis, 2013 102
Table 65: Portfolio Assessment – Other Players in Total Ankle Replacement Market, 2013 102
Table 66: Advantages and Disadvantages of Ankle Fusion and Total Ankle Replacement 104
Table 67: Sales Forecasts for APAC TAR Market (2009–2018) 115
Table 68: Sales Forecasts for TAR in Japan (2009–2018) 117
Table 69: Sales Forecasts for TAR in China (2009–2018) 119
Table 70: Sales Forecasts for TAR in India (2009–2018) 121
Table 71: Abbreviations 123
Table 72: Physicians Surveyed, By Country 135
List of Figures
Figure 1: Schematic Diagram of Ankle Anatomy 15
Figure 2: Ankle Arthritis Subtypes 16
Figure 3: Causes of Post-Traumatic Ankle Arthritis 17
Figure 4: Staged Treatment Approach of Ankle Arthritis 22
Figure 5: An Example of Ankle Distraction Arthroplasty 25
Figure 6: An Example of Ankle Fusion 26
Figure 7: An Example of a Total Ankle Replacement Implant 28
Figure 8: APAC Population with Ankle Arthritis (2009–2018) 30
Figure 9: Treatment Modalities of Ankle Arthritis in Developed Countries 31
Figure 10: Treatment Modalities of Ankle Arthritis in Developing Countries 31
Figure 11: Product Image – Agility LP 37
Figure 12: Product Image – Salto Talaris 39
Figure 13: Product Image – INBONE II 42
Figure 14: Product Image – TNK 44
Figure 15: Product Image – Zimmer Trabecular Metal Total Ankle 46
Figure 16: Product Image – STAR 48
Figure 17: Product Image – Mobility 51
Figure 18: Product Image – Salto 53
Figure 19: Product Image – HINTEGRA 55
Figure 20: Product Image – BOX 57
Figure 21: Product Image – Zenith 59
Figure 22: Product Image – CCI Evolution 61
Figure 23: Product Image – Akilos 75
Figure 24: TAR Procedure Volume in Asia-Pacific (2009–2018) 77
Figure 25: Sales Forecast for APAC TAR Market (2009–2018) 115
Figure 26: Market Sales for TAR by Region (2011–2018) 116
Figure 27: Sales Forecasts for TAR in Japan (2009–2018) 118
Figure 28: Sales Forecasts for TAR in China (2009–2018) 120
Figure 29: Sales Forecasts for TAR in India (2009–2018) 122
Companies Mentioned
Small Bone Innovation, Inc.
DePuy Synthes
Tornier N.V.
Wright Medical Group, Inc.
Integra LifeSciences
Zimmer Holdings, Inc.
Corin Group
KYOCERA Medical Corporation
MatOrtho
Implants International
To order this report:
Orthopedic Industry: MediPoint: Total Ankle Replacement - APAC Analysis and Market Forecasts
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001
SOURCE Reportlinker
Share this article